Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG)

Huayuan Zhu,Xiao Lu, Xiaoping Zhang,Haiying Hua, Jie Zhang,Yuqing Miao, Weiying Gu,Min Xu, Xuzhang Lu,Bingzong Li, Chunling Wang,Haiwen Ni, Jun Qian,Jinning Shi, Maozhong Xu, Guangqi Wu,Yunping Zhang, Qiudan Shen,Zhi Wang, Jianfeng Zhu, Zhen Cheng, Wanchuan Zhuang, Guoqiang Lin, Yongjun Hu, Qiurong Shan, Yifei Chen, Hongchun Qiu, Jianyong Li,Wenyu Shi

Annals of Hematology（2024）

引用 0|浏览2

暂无评分

摘要

Elderly patients with lymphoproliferative diseases (LPD) are vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we retrospectively described the clinical features and outcomes of the first time infection of Omicron SARS-CoV-2 in 364 elderly patients with lymphoma enrolled in Jiangsu Cooperative Lymphoma Group (JCLG) between November 2022 and April 2023 in China. Median age was 69 years (range 60–92). 54.4

查看译文

关键词

COVID-19,Omicron SARS-CoV-2,Elderly patients with lymphoma,CLL,BTK inhibitors,CD20 antibody

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要